AME Logo
NR

Natella Rakhmanina

MD, PhD, FAAP, FCP, AAHIVS

Children’s National Hospital, United States

Biography

Dr. Natella Rakhmanina is a Professor of Pediatrics at the George Washington University and serves as a Director of the HIV Program at Children’s National Hospital in Washington, DC, USA. Dr. Rakhmanina obtained her MD degree at People’s Friendship University in Moscow, Russia, and her PhD degree at the Erasmus University in Rotterdam, the Netherlands. For more than 20 years she has been providing clinical care to HIV-infected infants, children and adolescents, and continues her practice treating pediatric and adolescent patients in metropolitan DC area. She is certified in HIV medicine and is a successful clinical researcher, focusing her research on the treatment and prevention of HIV in children and adolescents and serving as a principal investigator of NIH, CDC and industry funded pediatric and adolescent HIV studies. Dr. Rakhmanina is also a Senior Technical Advisor at Elizabeth Glaser Pediatrics AIDS Foundation leading several projects on pediatric and adolescent HIV treatment in Sub-Saharan African countries. Dr. Rakhmanina is a Chair of the Committee on Pediatric AIDS at the American Academy of Pediatrics, member of the US Department of Health and Human Services Panel on the Pediatric Antiretroviral Therapy and Management Guidelines at the Office of AIDS Research Advisory Council in National Institutes of Health, member of the Pediatric Advisory Working Group at the World Health Organization, and a Regent of the Board and Chair of the Bylaws committee at the American College of Clinical Pharmacology.

LATEST RELATED MATERIALS

RELATED COURSES

CME Series | Long-Acting Anti-Infectives
HIV
COVID-19
RSV
Tuberculosis
Viral Hepatitis and Liver Disease
60 min
Richard Elion, Natella Rakhmanina, François Venter

CME Series | Long-Acting Anti-Infectives

This module focuses on the evolving landscape of long-acting anti-infective therapies, emphasizing recent advances in HIV prevention and treatment. Participants will explore current approved drugs and promising therapies in development, with a special focus on pediatric and adolescent populations. The module also addresses the challenges and opportunities for implementing long-acting antiretrovirals in resource-limited settings.

What Will Set You Apart?

By completing this module, you will:

  • Understand current and emerging long-acting drugs and therapies for HIV prevention
  • Evaluate the progress and challenges in developing long-acting anti-infective options for children and adolescents
  • Discuss the implementation of long-acting antiretroviral therapies in resource-limited settings

Is This Program for You?

This module is designed for clinicians, researchers, program managers, and public health professionals involved in HIV prevention and treatment. It is particularly relevant for those focused on pediatric and adolescent care, as well as those working in resource-limited environments where innovative therapeutic options are critical.

What Will You Cover in This Module?

  • Current and Future Perspectives in HIV Prevention
  • The Long-Acting Anti-Infective Agents for Children and Adolescents
  • Long-Acting Anti-Infectives in Resource-Limited Settings